Catyalyst Pharmaceutical Partners (CPRX) Posts Better than Expected Q4 Loss
Catyalyst Pharmaceutical Partners (NASDAQ: CPRX) reported Q4 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
